S&P 500
(-1.46%) 5 123.41 points
Dow Jones
(-1.24%) 37 983 points
Nasdaq
(-1.62%) 16 175 points
Oil
(0.51%) $85.45
Gas
(0.51%) $1.773
Gold
(-0.53%) $2 360.20
Silver
(-0.99%) $27.97
Platinum
(0.18%) $989.80
USD/EUR
(0.79%) $0.939
USD/NOK
(0.59%) $10.89
USD/GBP
(0.83%) $0.803
USD/RUB
(0.01%) $93.28

Realtime updates for Propanc Biopharma, Inc. [PPCB]

Exchange: PNK Industry: Biotechnology
Last Updated12 Apr 2024 @ 13:35

0.00% $ 0.00170

Live Chart Being Loaded With Signals

Commentary (12 Apr 2024 @ 13:35):

Propanc Biopharma, Inc., a biopharmaceutical company, focuses on the development of cancer treatments for patients with pancreatic, ovarian, and colorectal cancer in Australia...

Stats
Today's Volume 880 101
Average Volume 3.36M
Market Cap 5.59B
EPS $-0.0449 ( 2023-11-14 )
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -0.170
ATR14 $0 (0.00%)
Insider Trading
Date Person Action Amount type
2023-07-05 Zelinger Josef Buy 15 000 000 Common Stock Purchase Warrant
2021-08-17 Kenyon Julian Norman Buy 3 420 000 Common stock, par value $0.001
2021-08-17 Nathanielsz James Andrew Buy 5 928 000 Common stock, par value $0.001
2021-08-17 Nathanielsz James Andrew Buy 2 800 000 Common stock, par value $0.001
2021-08-17 Zelinger Josef Sell 0 Common stock, par value $0.001
INSIDER POWER
100.00
Last 22 transactions
Buy: 280 061 820 | Sell: 580 500

Propanc Biopharma, Inc. Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Propanc Biopharma, Inc. Financials

Annual 2023
Revenue: $0
Gross Profit: $-28 841.00 (0.00 %)
EPS: $-1.530
Q4 2023
Revenue: $0
Gross Profit: $-6 597.00 (0.00 %)
EPS: $-0.210
Q3 2023
Revenue: $0
Gross Profit: $-8 365.00 (0.00 %)
EPS: $-0.420
Q2 2023
Revenue: $0
Gross Profit: $-7 506.00 (0.00 %)
EPS: $-0.510

Financial Reports:

No articles found.

Propanc Biopharma, Inc.

Propanc Biopharma, Inc., a biopharmaceutical company, focuses on the development of cancer treatments for patients with pancreatic, ovarian, and colorectal cancer in Australia. Its lead product is PRP, a formulation that is in preclinical phase of development designed to enhance the anti-cancer effects of multiple enzymes acting synergistically. The company has a research collaboration with University of Jaén to commence the POP1 joint drug discovery program. The company was formerly known as Propanc Health Group Corporation and changed its name to Propanc Biopharma, Inc. in April 2017. Propanc Biopharma, Inc. was incorporated in 2007 and is based in Camberwell, Australia.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators